Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2005 1
2007 2
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

4 results
Results by year
Filters applied: . Clear all
Page 1
When prostate cancer meets bone: control by wnts.
Emami KH, Corey E. Emami KH, et al. Cancer Lett. 2007 Aug 18;253(2):170-9. doi: 10.1016/j.canlet.2006.12.040. Epub 2007 Apr 25. Cancer Lett. 2007. PMID: 17462819 Review.
Osteoprotegerin in prostate cancer bone metastasis.
Corey E, Brown LG, Kiefer JA, Quinn JE, Pitts TE, Blair JM, Vessella RL. Corey E, et al. Cancer Res. 2005 Mar 1;65(5):1710-8. doi: 10.1158/0008-5472.CAN-04-2033. Cancer Res. 2005. PMID: 15753366 Free article.
Host-derived RANKL is responsible for osteolysis in a C4-2 human prostate cancer xenograft model of experimental bone metastases.
Morrissey C, Kostenuik PL, Brown LG, Vessella RL, Corey E. Morrissey C, et al. BMC Cancer. 2007 Aug 3;7:148. doi: 10.1186/1471-2407-7-148. BMC Cancer. 2007. PMID: 17683568 Free PMC article.
The effect of osteoprotegerin administration on the intra-tibial growth of the osteoblastic LuCaP 23.1 prostate cancer xenograft.
Kiefer JA, Vessella RL, Quinn JE, Odman AM, Zhang J, Keller ET, Kostenuik PJ, Dunstan CR, Corey E. Kiefer JA, et al. Clin Exp Metastasis. 2004;21(5):381-7. doi: 10.1007/s10585-004-2869-0. Clin Exp Metastasis. 2004. PMID: 15672862 Free article.